AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.
about
AMP-activated protein kinase, stress responses and cardiovascular diseasesAlcoholic liver disease: pathogenesis, management, and novel targets for therapyCellular and molecular mechanisms of metformin: an overviewAlcoholic liver disease: pathogenesis and new therapeutic targets.PCK2 activation mediates an adaptive response to glucose depletion in lung cancerShort chain acyl-CoA dehydrogenase deficiency and short-term high-fat diet perturb mitochondrial energy metabolism and transcriptional control of lipid-handling in liverMetformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolismCOH-SR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese miceBerberine promotes glucose consumption independently of AMP-activated protein kinase activationShort and long-term impact of lipectomy on expression profile of hepatic anabolic genes in rats: a high fat and high cholesterol diet-induced obese modelEnvironmental pollution: a tangible risk for NAFLD pathogenesisA network biology workflow to study transcriptomics data of the diabetic liver.Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activationAMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?New therapeutic targets in alcoholic hepatitis.Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase.Protein kinase A is a target for aging and the aging heart.Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.Regulation of bile canalicular network formation and maintenance by AMP-activated protein kinase and LKB1.Effect of metformin on metabolic improvement and gut microbiotaAMP-activated protein kinase mediates apoptosis in response to bioenergetic stress through activation of the pro-apoptotic Bcl-2 homology domain-3-only protein BMFLinking epigenetics to lipid metabolism: focus on histone deacetylases.Sexually dimorphic effect of in vitro fertilization (IVF) on adult mouse fat and liver metabolomesImpact of metformin on reproductive tissues: an overview from gametogenesis to gestationEthanol and liver: recent insights into the mechanisms of ethanol-induced fatty liverT₃-induced liver AMP-activated protein kinase signaling: redox dependency and upregulation of downstream targetsGenistein, resveratrol, and 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway.Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice.Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling.A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells.Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissueAMPK inhibition in health and disease.Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagy.Maintenance of mouse hematopoietic stem cells ex vivo by reprogramming cellular metabolismContinued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted.Metformin-clinical pharmacology in PCOs.Antiobesogenic role of endothelial nitric oxide synthase.Carbohydrate metabolism is perturbed in peroxisome-deficient hepatocytes due to mitochondrial dysfunction, AMP-activated protein kinase (AMPK) activation, and peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) suppression.Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet
P2860
Q24610297-233C3373-500B-43E6-9F03-0B7C7514377CQ26861620-CA15653E-183A-46DD-9E7A-90F4FDD100FAQ27013561-484CA513-F202-426F-8112-CCC81FEF8A73Q27690220-F5A86944-586F-44EB-8528-88127CCB6507Q28235954-16571DE0-EF45-415A-B27F-5EC7F0F51832Q28388364-B31132B4-B914-414D-8AB0-A496289C8EB9Q28485245-2214EF63-4630-4CFE-A3D2-A32CCA43B7FDQ28537870-39CD8F1B-0224-4A45-98FA-A43B0E20E309Q28541332-8A1E518F-753B-4947-8EF6-6CAECC04F8E9Q28543388-509190F8-8137-4FA5-9749-445606D620DEQ28661241-94B101B2-EC7F-4260-81C0-F56B38FB4B74Q30869985-2B69E6DD-F46C-49EE-819D-F71C252AE691Q33637485-E84D4FBC-E815-40B9-8128-063EDE8DE63FQ33688657-5A365AF1-3443-4F7C-8179-2668321D1F3FQ33757267-40571011-DA6B-48DC-A6DE-4C5B3A06C562Q33796165-C7BA9154-6F90-4361-AC67-34E1464F458DQ33896774-77C29E0D-B4A8-4CDC-92AE-879261E6ADD0Q33968008-12A0A79F-172B-441F-A2E0-512A4A9CF1F9Q34129484-5943DEBE-0B1C-4C66-961A-BE031FDA76C0Q34261321-35F595B6-8968-47D2-A45B-14E9AFCEDB9DQ34285501-0BBB6A0D-F0B7-40BA-96B5-399611817D9EQ34308013-E8B6927F-EEA0-4039-BCDF-486E996D4555Q34343095-A4EBF0DD-FD19-4672-9BBA-DB9EE822E7AFQ34357928-3C94C575-5344-4B05-BEC7-3A96F9296C10Q34405039-A4E0AAAF-18A2-4ACF-8851-ED95D5F22C70Q34696633-73A4862B-4B03-4165-A49A-AB64C4C9EFC7Q34715847-D3A154CE-257D-46D7-8F36-9959FAB3C5FDQ35008532-C80640EC-964C-445E-BC59-E3F7BADCEE1BQ35015752-6E46608C-33BA-4A95-A23A-A5BEA1BD08DCQ35038522-1411956B-6D46-47BE-8A87-5BDBDF3F5911Q35041508-2FAD2C5E-CAE0-4CEC-BADB-988F6E28CC0BQ35094436-7548A6FF-F1CD-42E0-B322-6309DA9DFEFAQ35108275-86710B2D-2AEF-4B6F-82BD-BF401AAF8727Q35153207-CB091E58-EBFF-4AF7-9F63-2700C3DAFE5EQ35180053-E801102F-1AA5-4E8B-994E-D314DE27ABE5Q35349627-550C8CCB-643B-48E3-8B65-2E82CDDCE9C5Q35540257-71F9B35A-D292-415C-B49D-5CF41BCAC4D4Q35604967-3C6AD8E2-83EB-4D2E-A9CF-FF96A5C463D3Q35757790-505703EE-68CE-42E2-BC82-C2310614B5E6Q35832166-60F51CB2-F1B6-49D0-9342-8E92EB9A9A24
P2860
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AMP-activated protein kinase i ...... y to therapeutic perspectives.
@en
AMP-activated protein kinase i ...... y to therapeutic perspectives.
@nl
type
label
AMP-activated protein kinase i ...... y to therapeutic perspectives.
@en
AMP-activated protein kinase i ...... y to therapeutic perspectives.
@nl
prefLabel
AMP-activated protein kinase i ...... y to therapeutic perspectives.
@en
AMP-activated protein kinase i ...... y to therapeutic perspectives.
@nl
P2093
P2860
P50
P1433
P1476
AMP-activated protein kinase i ...... gy to therapeutic perspectives
@en
P2093
P2860
P356
10.1111/J.1748-1716.2009.01970.X
P577
2009-02-19T00:00:00Z